Cannabis Investing Newsletter

Learn To Pick The Best Cannabis Stocks

Cannabis Stocks Forum & Discussion

Welcome to the Cannabis Investing Newsletter Forum. This is for the cannabis stocks forum & discussion. Feel free to find your favorite cannabis stocks and contribute content as you please; content that continues the discussion of, and analysis of, cannabis stocks. – D. H. Taylor

Notifications
Clear all

MariMed To Buy Maryland Medical Marijuana License Holder Kind Therapeutics For $20M


#1
 #1
(@1)
Estimable Member Registered
Joined: 4 months ago
Posts: 156
Topic starter  

 

MariMed To Buy Maryland Medical Marijuana License Holder Kind Therapeutics For $20M

8:09 am ET January 5, 2022 (Benzinga) Print

Multi-state cannabis company MariMed Inc. (OTCQX: MRMD) will acquire Kind Therapeutics U.S.A., LLC, a vertically integrated marijuana business in Maryland for $20 million. The Norwood, Massachusetts-based company confirmed Wednesday it has signed a definitive purchase agreement.

Once the transaction is completed, Kind’s financial results with be reported by the company on a consolidated basis.

“I am pleased to announce our agreement to acquire Kind, which operates in one of the top medical cannabis programs and markets in the country,” Bob Fireman, CEO of MariMed stated. “This acquisition will deliver another transformational year for MariMed in 2022, building on two consecutive years of more than 100% cannabis revenue and Adjusted EBITDA growth.”

The Deal Summary

The aggregate purchase price to be paid for Kind, in a combination of cash and promissory notes, will be $20 million.

In addition, the company will acquire the minority interests of one of the current owners of Kind in two subsidiaries of the company that own cannabis facilities in Maryland and Delaware for $2 million in the aggregate. Further, upon the closing of these transactions, all Kind related litigation will be dismissed with prejudice.

The transaction makes Maryland the third state in which MariMed will have acquired a licensed cannabis business it manages and assisted in developing. The other two are Massachusetts and Illinois. This acquisition is part of the company’s strategic growth plan to consolidate the multiple state cannabis businesses it organically developed and manages.

Kind, which holds cannabis licenses for cultivation and production, as well as a provisional license for a dispensary, currently leases from Mari Holdings MD, LLC, a MariMed subsidiary, a 180,000 square foot cultivation and processing facility in Hagerstown, which MariMed developed. Mari Holdings MD, LLC also owns and is developing a dispensary facility for Kind in Annapolis, which is expected to open in early 2022.

Price Action

MariMed’s shares closed Wednesday market session 0.41% lower at $0.9 per share.

Photo by Elsa Olofsson on Unsplash


Quote
Matt Paul
(@mattpaul02yahoo-com)
Eminent Member
Joined: 3 months ago
Posts: 37
 
This is another huge step for Bob Fireman, Chief Executive Officer of MariMed - This acquisition will deliver another transformational year for MariMed in 2022, building on two consecutive years of more than 100% cannabis revenue and Adjusted EBITDA growth.

The aggregate purchase price to be paid for Kind, in a combination of cash and promissory notes, will be $20 million. In addition, the Company will acquire the minority interests of one of the current owners of Kind in two subsidiaries of the Company that own cannabis facilities in Maryland and Delaware for $2 million in the aggregate. Further, upon the closing of these transactions, all Kind related litigation will be dismissed with prejudice.

Maryland’s legal medical cannabis program currently has more than 139,000 registered patients and, according to the Maryland Medical Cannabis Commission (“MMCC”), the state receives more than 200 applications for medical cannabis cards every day. Maryland’s medical cannabis program was on pace to generate more than $500 million in sales in 2021. According to Cowen Research, with a population of 6.2 million, Maryland’s medical cannabis program boasts some of the highest rates of registered medical consumers, incidence usage and spending, on a per capita basis, among all legal medical cannabis programs in the U.S. The state legislature is reviewing proposals to implement an adult use cannabis program in the future.

 

 

Regards,
Matt P.


ReplyQuote



D. H. Taylor
(@dhtaylor)
Member Admin
Joined: 2 years ago
Posts: 689
 

@mattpaul02yahoo-com MariMed is going to be so huge.  I know how much you love this stock... and so do I. I think these guys are going to crush it for years.  A few bumps within the industry until we get there.  


ReplyQuote

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 10MB

 
Preview 0 Revisions Saved
Share:



Copyright Cannabis Investing Newsletter 2021 - 2022